Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lysine is an essential amino acid that humans must obtain through diet or supplementation. In clinical and therapeutic contexts, it is most frequently utilized as a nutraceutical for the management and prevention of Herpes Simplex Virus (HSV) outbreaks, particularly cold sores. The primary mechanism of action involves the competitive antagonism of arginine; HSV requires arginine-rich proteins for its replication cycle. By increasing the systemic lysine-to-arginine ratio, lysine supplementation is thought to inhibit viral protein synthesis and suppress viral growth. While widely used and available over-the-counter, clinical evidence regarding its efficacy for HSV remains mixed, and it is generally classified as a dietary supplement rather than a primary pharmaceutical antiviral.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lysine.